title: Single-dose antibiotic prophylaxis for patients undergoing extended pelvic surgery for gynecologic malignancy.
abstract: The comparative efficacy of single-dose antibiotic prophylaxis was retrospectively evaluated in 116 patients undergoing extended pelvic surgical procedures with curative intent. During the 24-month period, other important variables such as surgeon's experience, duration of preoperative hospitalization, preoperative preparation, method of hair removal, suture type, suture size, use of drains, use of cautery, and abdominal closure were controlled. The overall surgical site infection rate was 4.3% after radical hysterectomy with lymphadenectomy and 4.5% after total hysterectomy with lymphadenectomy. In this clinical situation the use of a single dose of antibiotic prophylaxis theoretically decreases cost and patient exposure and appears to be as efficacious as a multiple-dose regimen.
authors.affiliation: Division of Gynecologic Oncology, Watson Clinic, Lakeland, FL 33805.
authors.forename: J W
authors.initials: JW
authors.lastname: Orr
authors.forename: P F
authors.initials: PF
authors.lastname: Sisson
authors.forename: B
authors.initials: B
authors.lastname: Patsner
authors.forename: J M
authors.initials: JM
authors.lastname: Barrett
authors.forename: J R
authors.initials: JR
authors.lastname: Ellington
authors.forename: R H
authors.initials: RH
authors.lastname: Jennings
authors.forename: K B
authors.initials: KB
authors.lastname: Paredes
authors.forename: D L
authors.initials: DL
authors.lastname: Taylor
authors.forename: S J
authors.initials: SJ
authors.lastname: Soong
authors.forename: C
authors.initials: C
authors.lastname: Roe
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D005833:Genital Neoplasms, Female / Q000601:surgery*; D006801:Humans; D007044:Hysterectomy; D008198:Lymph Nodes / Q000601:surgery; D008795:Metronidazole / Q000627:therapeutic use; D010388:Pelvis / Q000601:surgery*; D013530:Surgical Wound Infection / Q000517:prevention & control*
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D008795:Metronidazole